A newly published manuscript authored by Dr. Gunda Georg, YourChoice Therapeutics and Columbia University Medical Center ...
Self-administered injectable contraceptives, which are progestin-only shots taken at home every three months, have been ...
A study reveals that many clinicians remain unaware of self-administered injectable contraception, despite its decades-long ...
ZME Science on MSN
This FDA Approved Birth Control Method Is Effective But Your Doctor Probably Never Mentioned It
“Since most physicians don’t know that this is an option, patients don’t know about it. It’s safe, effective, and puts the ...
News-Medical.Net on MSN
New publication describes the chemical journey of non-hormonal male birth control pill
A newly published manuscript authored by Dr. Gunda Georg, YourChoice Therapeutics and Columbia University Medical Center ...
Bayer today announced it has partnered with actress and menopause advocate Gabrielle Union-Wade on the ‘Life Doesn’t Stop for ...
Launched KOMZIFTI™ (ziftomenib), first and only once-daily, oral menin inhibitor approved for adults with R/R NPM1-mutated ...
Main outcome measures Cumulative time dependent intake of preservatives, including those in industrial food brands, assessed ...
The Maternal Care Bundle (MCB) sets best practice standards across 5 areas of clinical care, for implementation by NHS providers and commissioners across England. The aim is to reduce maternal ...
Enbridge's dividend safety is underpinned by consistent free cash flow and prudent capital structure. Read why ENB stock is a ...
The recent update to Viatris centers on a refreshed US$16 price target, set against a fair value estimate that has inched ...
Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 months Notable responses were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback